831 related articles for article (PubMed ID: 33845483)
1. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
Stukalov A; Girault V; Grass V; Karayel O; Bergant V; Urban C; Haas DA; Huang Y; Oubraham L; Wang A; Hamad MS; Piras A; Hansen FM; Tanzer MC; Paron I; Zinzula L; Engleitner T; Reinecke M; Lavacca TM; Ehmann R; Wölfel R; Jores J; Kuster B; Protzer U; Rad R; Ziebuhr J; Thiel V; Scaturro P; Mann M; Pichlmair A
Nature; 2021 Jun; 594(7862):246-252. PubMed ID: 33845483
[TBL] [Abstract][Full Text] [Related]
2. Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies.
Davies JP; Almasy KM; McDonald EF; Plate L
ACS Infect Dis; 2020 Dec; 6(12):3174-3189. PubMed ID: 33263384
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.
Ahsan N; Rao RSP; Wilson RS; Punyamurtula U; Salvato F; Petersen M; Ahmed MK; Abid MR; Verburgt JC; Kihara D; Yang Z; Fornelli L; Foster SB; Ramratnam B
Proteomics; 2021 May; 21(10):e2000279. PubMed ID: 33860983
[TBL] [Abstract][Full Text] [Related]
5. Proteome-wide data analysis reveals tissue-specific network associated with SARS-CoV-2 infection.
Feng L; Yin YY; Liu CH; Xu KR; Li QR; Wu JR; Zeng R
J Mol Cell Biol; 2020 Jun; 12(12):946-957. PubMed ID: 32642770
[TBL] [Abstract][Full Text] [Related]
6. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.
Haas P; Muralidharan M; Krogan NJ; Kaake RM; Hüttenhain R
J Proteome Res; 2021 Feb; 20(2):1133-1152. PubMed ID: 33464917
[TBL] [Abstract][Full Text] [Related]
7. Spatial and temporal roles of SARS-CoV PL
Yan S; Wu G
FASEB J; 2021 Jan; 35(1):e21197. PubMed ID: 33368679
[TBL] [Abstract][Full Text] [Related]
8. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.
Messina F; Giombini E; Montaldo C; Sharma AA; Zoccoli A; Sekaly RP; Locatelli F; Zumla A; Maeurer M; Capobianchi MR; Lauria FN; Ippolito G
Cell Death Dis; 2021 Aug; 12(8):788. PubMed ID: 34385425
[TBL] [Abstract][Full Text] [Related]
9. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
[TBL] [Abstract][Full Text] [Related]
10. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.
Atzrodt CL; Maknojia I; McCarthy RDP; Oldfield TM; Po J; Ta KTL; Stepp HE; Clements TP
FEBS J; 2020 Sep; 287(17):3633-3650. PubMed ID: 32446285
[TBL] [Abstract][Full Text] [Related]
11. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
[TBL] [Abstract][Full Text] [Related]
12. Potential Pathogenicity Determinants Identified from Structural Proteomics of SARS-CoV and SARS-CoV-2.
Prates ET; Garvin MR; Pavicic M; Jones P; Shah M; Demerdash O; Amos BK; Geiger A; Jacobson D
Mol Biol Evol; 2021 Jan; 38(2):702-715. PubMed ID: 32941612
[TBL] [Abstract][Full Text] [Related]
13. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2-host proteome interactions for antiviral drug discovery.
Liu X; Huuskonen S; Laitinen T; Redchuk T; Bogacheva M; Salokas K; Pöhner I; Öhman T; Tonduru AK; Hassinen A; Gawriyski L; Keskitalo S; Vartiainen MK; Pietiäinen V; Poso A; Varjosalo M
Mol Syst Biol; 2021 Nov; 17(11):e10396. PubMed ID: 34709727
[TBL] [Abstract][Full Text] [Related]
15. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
Bojkova D; Klann K; Koch B; Widera M; Krause D; Ciesek S; Cinatl J; Münch C
Nature; 2020 Jul; 583(7816):469-472. PubMed ID: 32408336
[TBL] [Abstract][Full Text] [Related]
16. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.
Krishnamoorthy P; Raj AS; Roy S; Kumar NS; Kumar H
Comput Biol Med; 2021 Jan; 128():104123. PubMed ID: 33260034
[TBL] [Abstract][Full Text] [Related]
17. ORF8a as a viroporin in SARS-CoV-2 infection?
Zandi M
Cytokine Growth Factor Rev; 2021 Oct; 61():1. PubMed ID: 34362671
[No Abstract] [Full Text] [Related]
18. p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1.
Ma-Lauer Y; Carbajo-Lozoya J; Hein MY; Müller MA; Deng W; Lei J; Meyer B; Kusov Y; von Brunn B; Bairad DR; Hünten S; Drosten C; Hermeking H; Leonhardt H; Mann M; Hilgenfeld R; von Brunn A
Proc Natl Acad Sci U S A; 2016 Aug; 113(35):E5192-201. PubMed ID: 27519799
[TBL] [Abstract][Full Text] [Related]
19. Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research.
Praissman JL; Wells L
Mol Cell Proteomics; 2021; 20():100103. PubMed ID: 34089862
[TBL] [Abstract][Full Text] [Related]
20. H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection.
Zhou N; Bao J; Ning Y
BMC Bioinformatics; 2021 Jan; 22(1):18. PubMed ID: 33413085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
